Over the past several years, the healthcare industry as a whole has experienced an abundance of mergers and acquisitions – major players are buying up their peers in deals ranging from millions to billions. The trend is continuing, and the healthcare playing field continues to be shaped by these mega-transactions.
For the medical device industry, 2017 is already proving to be a busy year full of deals that are changing the landscape. In just 6 months, we’ve seen seen groundbreaking deals like Abbott’s $25 billion acquisition of St. Jude, Becton Dickinson’s $24 billion purchase of C.R. Bard and Medtronic’s $6.1 billion divestiture of its patient monitoring and recovery biz to Cardinal Health.
